Cite
APA Citation
Gadaud, N., Leroy, H., Bérard, E., Tavitian, S., Leguay, T., Dimicoli-Salazar, S., Rieu, J., Luquet, I., Largeaud, L., Bidet, A., Delabesse, E., Klein, E., Sarry, A., de Grande, A., Bories, P., Pigneux, A., Récher, C., Dumas, P., & Bertoli, S. (2022). azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study. Leukemia & lymphoma, 63(6), 1398–1406. http://access.bl.uk/ark:/81055/vdc_100156413373.0x000038